Novo Nordisk ( NVO 1.82%) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...

Respondents see the glucagon-like peptide 1 (GLP-1) drugs as a major advance. They also have concerns about whether insurers ...

While medications like Wegovy promise quick results, many people still prefer a drug-free path to shedding pounds. Science ...

Struggling to find weight-loss drugs like Ozempic? Dr. Scourboutakos has 8 diet hacks that mimic the effects of GLP-1 meds for free. Turns out, tweaking your meals can help you shed pounds and prevent ...

Explore Viking's innovative GLP-1/GIP & THR-β therapies, with strong Phase 2/3 results, targeting major markets with ...

Lehigh Valley health experts discuss obesity, energy management, Medicaid changes, and GLP-1 drug trends at LVBCH’s 45th ...

Glucagon-like peptide-1 receptor agonists are tied to a reduction in alcohol intake in patients being treated for obesity.

Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, ...

Prediabetes is a clinical inflection point and a modifiable risk state. Small shifts in care can translate to big shifts in ...

Viking Therapeutics' VENTURE-Oral study of VK2735 has completed enrollment, with a readout set for H2'25. Learn why VKTX ...